Seeking Alpha

Furiex Pharmaceuticals (FURX -1%) slips today, in spite of its earlier announcement of a $5M...

Furiex Pharmaceuticals (FURX -1%) slips today, in spite of its earlier announcement of a $5M milestone payment from the Menarini Group for the launch of Priligy in France. The drug is currently marketed by FURX  in 16 countries in Europe, Asia and Latin America, and is approved in 56 countries worldwide.  Under the it's agreement with Menarini, FURX is eligible to receive up to $40M in sales-based milestones, plus tiered royalties ranging from the mid-teens to mid-twenties in percentage terms.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)